Finally, we found patients who had relatively higher levels of LINC00336 are associated with poor overall survival from lung cancers; this was assessed through a Kaplan–Meier analysis of a cohort of patients with lung cancer (Fig. 1j, k), indicating that LINC00336 might be used as a biomarker of NSCLC. Here, LINC00336 is linked to lung carcinoma.